Molecular Data Inc
NASDAQ:MKD
Molecular Data Inc
Research & Development
Molecular Data Inc
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Molecular Data Inc
NASDAQ:MKD
|
Research & Development
-¥35m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Research & Development
-¥52.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-27%
|
|
Pinduoduo Inc
NASDAQ:PDD
|
Research & Development
-¥11B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-58%
|
CAGR 10-Years
N/A
|
|
JD Health International Inc
HKEX:6618
|
Research & Development
-¥1.1B
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
|
Meituan
HKEX:3690
|
Research & Development
-¥21.2B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
JD.Com Inc
HKEX:9618
|
Research & Development
-¥16.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-33%
|
See Also
What is Molecular Data Inc's Research & Development?
Research & Development
-35m
CNY
Based on the financial report for Dec 31, 2020, Molecular Data Inc's Research & Development amounts to -35m CNY.
What is Molecular Data Inc's Research & Development growth rate?
Research & Development CAGR 3Y
-25%
Over the last year, the Research & Development growth was 22%. The average annual Research & Development growth rates for Molecular Data Inc have been -25% over the past three years .